We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$8.17B
1-Year Est. Return
68.82%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
(+0.57%)
Cap. Flow
+$188M
Cap. Flow
% of AUM
3.27%
Top 10 Holdings %
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$136M |
| 2 |
Freshpet
FRPT
|
+$91.3M |
| 3 |
Ross Stores
ROST
|
+$81.3M |
| 4 |
Five Below
FIVE
|
+$72.6M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$75.6M |
| 2 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$71.5M |
| 3 |
Illumina
ILMN
|
+$62.5M |
| 4 |
AstraZeneca
AZN
|
+$55.2M |
| 5 |
Tractor Supply
TSCO
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.48% |
| 2 | Miscellaneous | 31.17% |
| 3 | Consumer Discretionary | 9.47% |
| 4 | Consumer Staples | 8.21% |
| 5 | Technology | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
201
AstraZeneca
AZN
$248B
| – | – |
-418,000
| Closed | -$55.2M |
|
202
Biofrontera
BFRI
$23.2M
| – | – |
-38,182
| Closed | -$1.42M |
|
|
SLAI
203
DELISTED
SOLAI Ltd ADS
SLAI
| – | – |
-73,525
| Closed | -$3.19M |
|
204
Burlington
BURL
$15.9B
| – | – |
-295,921
| Closed | -$40.3M |
|
205
Celularity
CELU
$44.9M
| – | – |
-186,813
| Closed | -$6.35M |
|
206
Creative Medical Technology
CELZ
$7.25M
| – | – |
-124,418
| Closed | -$933K |
|
|
CPRX
207
DELISTED
Catalyst Pharmaceutical
CPRX
| – | – |
-10,200,000
| Closed | -$71.5M |
|
208
Carter's
CRI
$1.19B
| – | – |
-87,662
| Closed | -$6.18M |
|
209
Cisco
CSCO
$430B
| – | – |
-256,000
| Closed | -$10.9M |
|
|
210
Dollar General
DG
$28.3B
| – | – |
-308,143
| Closed | -$75.6M |
|
211
Dermata Therapeutics
DRMA
$6.29M
| – | – |
-265
| Closed | -$414K |
|
|
EA
212
DELISTED
Electronic Arts
EA
| – | – |
-40,000
| Closed | -$4.87M |
|
213
Edesa Biotech
EDSA
$46.2M
| – | – |
-146,182
| Closed | -$1.65M |
|
214
Energy Focus
EFOI
$18.5M
| – | – |
-87,473
| Closed | -$796K |
|
|
HYPD
215
Hyperion DeFi Inc
HYPD
$55M
| – | – |
-24,178
| Closed | -$3.77M |
|
216
FIVE9
FIVN
$2.34B
| – | – |
-65,000
| Closed | -$5.92M |
|
217
Greenlane Holdings
GNLN
$1.96M
| – | – |
-1
| Closed | -$1.86M |
|
218
GeoVax Labs
GOVX
$2.44M
| – | – |
-3,623
| Closed | -$1.13M |
|
219
HubSpot
HUBS
$12.2B
| – | – |
-18,000
| Closed | -$5.41M |
|
|
220
Illumina
ILMN
$32B
| – | – |
-348,492
| Closed | -$62.5M |
|
221
iShares Russell 2000 ETF
IWM
$80.3B
| – | – |
-33,500
| Closed | -$6.11M |
|
222
Jazz Pharmaceuticals
JAZZ
$15.6B
| – | – |
-278,000
| Closed | -$43.4M |
|
223
Monster Beverage
MNST
$84.6B
| – | – |
-336,000
| Closed | -$7.79M |
|
224
M&T Bank
MTB
$34.6B
| – | – |
-188,000
| Closed | -$30M |
|
|
NCEL
225
NewcelX Ltd
NCEL
$19M
| – | – |
-3,041
| Closed | -$714K |
|
Similar funds
MWM
BP
FWCM
SC
SFM
EHC
BIM
WF
Armistice Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.
- Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
- Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
- Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
- Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
- Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
- Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
- Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.
Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.